The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients

European Radiology

Volumn 11, Issue 2, 2001, Pages 229-235

  Vilanova, J C ^a   Comet, J ^a   Capdevila, A ^a   Barcelo J ^a   Dolz, J L ^a   Huguet, M ^a   Barcelo C ^a   Aldoma J ^a   Delgado, E ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Magnetic resonance; Neoplasms; Prostate; Surface coils

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ADULT; AGED; ARTICLE; CALCULATION; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALPATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; ECHO-PLANAR IMAGING; ENDOSONOGRAPHY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RECTUM; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 0034879737     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300000616     Document Type: Article

References (29)

1. Cancer statistics, 1997
2. Prostate-specific antigen and screening for prostate cancer: Much ado about something
3. Screening for prostate cancer: More questions than Answers
4. Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study
5. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6630 men
6. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy
7. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
8. Economic considerations of prostate cancer: The role of detection specificity and biopsy reduction
9. An assessment of the usefulness of serum prostate-specific antigen level and cancer volume in biopsy specimens to predict the extent of prostate cancer
10. Correlation between pre-operative predictors and pathologic features in radical prostatectomy specimens in PSA-based screening
11. Predictors for biopsy outcome in the European randomized study of screening for prostate cancer
12. Anatomy and pathology of the male pelvis by magnetic resonance imaging
13. Prostatic disorders: MR imaging at 1.5T
14. Prostate: MR imaging with an endorectal coil
15. Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation
16. Nonpalpable prostate cancer: Detection with MR imaging
17. Carcinoma of prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array
18. Benefits and costs of MR imaging of prostate cancer
19. Prostate-specific antigen as a screening test. The Netherlands experience
20. Interexaminer variability of digital rectal examination in detecting prostate cancer
21. Prostate cancer awareness week, 1989-1992: Lessons in the early detection of prostate cancer
22. Histopatology of prostate cancer: Prediction of malignant behavior and correlation with ultrasonography
23. Efficacy of transrectal ultrasound for identification of clinically undetected prostate cancer
24. Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate
25. Staging of prostate cancer: Results of radiology diagnostic oncology group project comparison of three MR imaging techniques
26. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer
27. Prostate carcinoma: Assessment of diagnostic criteria for capsular penetration on endorectal coil MR images
28. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer
29. Role of percent positive biopsies and endorectal coil MRI in predicting prognosis in intermediate-risk prostate cancer patients